Filing Details

Accession Number:
0001209191-15-084476
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-10 16:12:09
Reporting Period:
2015-12-08
Filing Date:
2015-12-10
Accepted Time:
2015-12-10 16:12:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1503802 Karyopharm Therapeutics Inc. KPTI Pharmaceutical Preparations (2834) 263931704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588389 Raza Mansoor Mirza C/O Karyopharm Therapeutics Inc.
85 Wells Avenue
Newton MA 02459
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-08 2,556 $0.03 6,818 No 4 M Direct
Common Stock Disposition 2015-12-08 2,556 $15.01 4,262 No 4 S Direct
Common Stock Acquisiton 2015-12-08 6,061 $0.03 10,323 No 4 M Direct
Common Stock Disposition 2015-12-08 6,061 $15.01 4,262 No 4 S Direct
Common Stock Acquisiton 2015-12-08 2,121 $0.26 6,383 No 4 M Direct
Common Stock Disposition 2015-12-08 6,383 $15.01 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-12-08 2,556 $0.00 2,556 $0.03
Common Stock Stock Option (Right to Buy) Disposition 2015-12-08 6,061 $0.00 6,061 $0.03
Common Stock Stock Option (Right to Buy) Disposition 2015-12-08 2,121 $0.00 2,121 $0.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-11-04 No 4 M Direct
0 2021-01-20 No 4 M Direct
6,099 2021-12-13 No 4 M Direct
Footnotes
  1. This option, representing a right to purchase a total of 9,091 shares, vested as to 25% of the shares on November 5, 2011, and the remaining 75% of the shares vested in 36 equal monthly installments thereafter.
  2. This option, representing a right to purchase a total of 6,061 shares, vested as to 25% of the shares on October 22, 2011, and the remaining 75% of the shares vested in 36 equal monthly installments thereafter.
  3. This option, representing a right to purchase a total of 8,220 shares, vested as to 25% of the shares on December 12, 2012, with the remaining 75% vesting in 36 equal monthly installments thereafter.